Search dm+d | This VMP cannot be matched against our prescribing data.
| Name | Pregabalin 165mg modified-release tablets |
| Virtual Therapeutic Moiety | Pregabalin |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | tablet |
| Unit dose unit of measure | tablet |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Pregabalin |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 165.000 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | tabletmodified-release.oral |
| Dose Form | |
| Formulation | Modified-release tablet |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | Schedule 3 (CD No Register Exempt Safe Custody) |
| Actual Medicinal Products | |
| Misabri PR 165mg pro-longed release tablets (CNX Therapeutics Ltd) | |
| Virtual Medicinal Product Packs | |
| Pregabalin 165mg modified-release tablets 30 tablet | |
dm+d data retrieved from TRUD: release NHSBSA_12.3.0_20241223000001, imported on 24th December 2024 at 03:51:32.